semaglutide news today The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added A secret shopper study found

Oral semaglutide (3, 7, 14 mg daily) becomes the first oral GLP-1 receptor agonist approved by the FDA, using SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) absorption enhancer technology

link FAQ 9 QUESTIONS What is ipamorelin

69 Cooking meals in batches for easy leftovers

Recurrent acute rhinosinusitis: a single blind clinical study of N-acetylcysteine vs ambroxol associated to corticosteroid

For patients with diabetes who are advised to stop their GLP-1 medication: You should receive specific guidance on alternative glucose management during this period Blood glucose monitoring may need to be increased Temporary adjustments to other diabetes medications might be necessary Follow the JBDS perioperative diabetes management guidance or your local Trust protocol For emergency surgery , stopping GLP-1 medications in advance is not possible, and anaesthetists will take additional precautions to manage aspiration risk